Jin Medical International Ltd. (ZJYL) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential
Current Price
$2.20
Price Target
—
Target Range
— — —
Analyst Rating
—
Forward P/E—
Trailing P/E93.6x
Forward PEG—
Implied Growth—
Median Target—
Analyst Spread—
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$—
—
Consensus
$—
—
Bull Case
$—
—
Valuation Model TargetsConfidence: 42/100
Bear$2
Base$4
Bull$7
ZJYL Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Jin Medical International Ltd. (ZJYL) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $344M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, ZJYL trades at a trailing P/E of 93.6x.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $3.54, with bear and bull scenarios of $1.84 and $7.30 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+34.8%
Avg Forward P/E80.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MPWRMonolithic Power Systems, Inc. | $77.4B | $1575.96 | $1615.00 | +2.5% | Buy | 73.1x | 25 |
 NVCRNovoCure Limited | $1.9B | $16.83 | $33.50 | +99.0% | Buy | — | 15 |
 LFUSLittelfuse, Inc. | $11.1B | $441.58 | $400.00 | -9.4% | Buy | 33.8x | 11 |
 GKOSGlaukos Corporation | $7.9B | $134.15 | $146.67 | +9.3% | Buy | — | 24 |
 INVAInnoviva, Inc. | $1.9B | $22.80 | $37.67 | +65.2% | Buy | 11.9x | 10 |
 OSUROraSure Technologies, Inc. | $225M | $3.13 | $4.00 | +27.8% | Hold | — | 13 |
 LMATLeMaitre Vascular, Inc. | $2.5B | $107.91 | $101.50 | -5.9% | Buy | 37.2x | 20 |
 ATRCAtriCure, Inc. | $1.4B | $27.80 | $50.67 | +82.3% | Buy | 370.7x | 19 |
 MDTMedtronic plc | $99.9B | $77.96 | $109.50 | +40.5% | Buy | 14.1x | 49 |
 SYKStryker Corporation | $112.7B | $294.25 | $403.69 | +37.2% | Buy | 19.6x | 50 |
Upside Potential Comparison
NVCRATRCINVAMDTSYKOSURGKOSMPWRSee ZJYL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZJYL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZJYL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
What is the ZJYL stock price target for 2026?
The consensus price target for ZJYL is $N/A, close to the current price of $2.2 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.
Is ZJYL a buy, sell, or hold?
ZJYL has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
Is ZJYL stock overvalued or undervalued?
ZJYL's current price is $2.2 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
How high can ZJYL stock go?
The most bullish Wall Street analyst has a price target of $N/A for ZJYL, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $7 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ZJYL stock?
ZJYL is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ZJYL stock forecast?
The 12-month ZJYL stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A". Our proprietary valuation model produces a base case fair value of $4, with bear/bull scenarios of $2/$7.
What is ZJYL's fair value based on fundamentals?
Our quantitative valuation model calculates ZJYL's fair value at $4 (base case), with a bear case of $2 and bull case of $7. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
Should I buy ZJYL stock?
ZJYL appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ZJYL price targets vary so much?
ZJYL analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $2-$7 range provides an independent fundamental perspective.